Get more information on Omega 3 Supplements Market - Request Sample Report
The Omega 3 supplements market was valued USD 7 billion in 2023 and is estimated to reach USD 15 billion by 2032. From 2024 to 2032 & grow at a CAGR of 8.8%.
The increased acceptance of omega-3 supplements to meet daily nutritional requirements and maintain optimum organ health by the older population in industrialized economies such as the United States, Germany, United Kingdom, and France is expected to fuel demand. The worldwide omega-3 supplements market is being driven by rising end-user demand and rising consumer knowledge about healthy eating and the health advantages of omega-3. The sector is made up of two segments: -3 fatty acids and n-3 fatty acids, both of which contribute considerably to the size of the omega 3 fatty acids market. However, high costs and strict regulatory restrictions are likely to stifle industry growth. Furthermore, compared to the saturated markets of North America and Europe, Asia-Pacific is expected to rise significantly.
Due to the low cost of vegetal sources such as vegetable oil, nuts and seeds, and soya products, the market share of omega-3 fish oil is predicted to decline.
KEY DRIVERS:
Chronic disease awareness is growing.
Increased attention to cognitive development
RESTRAINTS:
Lack of consumer understanding of the daily recommended consumption
OPPORTUNITIES:
Product Development
Customers' attention has moved from reaction to prevention as a result of the corona virus outbreak.Consumers are placing a greater emphasis on immune health, heart health, and overall well-being. If infected with COVID-19, stroke survivors and people with cardiac problems such as high blood pressure and congenital heart defects may have an increased risk of consequences, according to the American Heart Association. As a result, demand for supplements to reduce the risk of heart failure grew, positively boosting product sales.
Global omega-3 supplements market is divided into four categories based on type, source, application, and location. The market is divided into three types of omega-3 acids: ALA (alpha-linolenic acid), DHA (docosahexaenoic acid), and EPA (eicosapentaenoic acid) (eicosapentaenoic acid). In 2023, DHA dominated the overall market, accounting for more than three-quarters of revenue, while the ALA and EPA combined accounted for one-fourth of revenue. With a CAGR of 8.8% from 2023 ALA is the fastest rising form of omega-3. Omega-3 is also categorized according to its sources, which include marine, nuts and seeds, vegetable oils, and soy and soy products.
The market is further divided into dietary supplements, medicines, infant formulae, food & drinks, pet food, and fish feed based on Omega-3 uses. The market for Omega-3 supplements is a significant element of the global industry. Pharmaceutical application is growing at a rapid pace with a CAGR of 15% from 2023 to 2032. The global market is divided into four regions: North America, Europe, Asia-Pacific, and Latin America and the Caribbean. North America is the largest market region, accounting for more than one-third of total revenue in 2020, followed by Asia-Pacific and Europe.
In 2020, North America dominated the market, accounting for 37.7% of worldwide sales. Obesity and lifestyle-related disorders are on the rise as a result of poor eating habits and the widespread availability of processed and ready-to-eat (RTE) foods. According to a study conducted by the New York State Government in March 2019, around 610,000 Americans die each year from heart disease.
In North America, coronary heart disease (CHD) is the leading cause of death for both men and women, making cardiovascular health one of the most important applications of omega 3 supplements. Food has evolved into functional foods and supplements, which can provide several health benefits in addition to basic sustenance.
As a result, items containing omega fatty acids, such as fortified meals and dietary supplements, are projected to be in high demand in the regional market. Due to increased sporting activities, Asia Pacific is expected to see considerable growth due to higher expenditure on health-enhancing items.Increased malnutrition rates and an ageing population are also contributing to the increase.
Need any customization research on Omega 3 Supplements Market - Enquiry Now
The key players are Nordic Naturals, Inc., NutriGold Inc., Reckitt Benckiser Group plc, Pharma Nord B.V, i-Health, Inc, Aker BioMarine AS, Luhua Biomarine (Shandong) Co., Ltd, Pharmavite LLC, KD Pharma Group, NOW Foods, GlaxoSmithKline plc, Natrol LLC, Carlson Laboratories, OmegaBrite, Optimum Nutrition, Inc., VAYA Pharma, Vital Choice Wild Seafood & Organics, SPC, Bionova, The Nature’s Bounty Co., Arkopharma and Other Players.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | US$ 7 Billion |
| Market Size by 2032 | US$ 15 Billion |
| CAGR | CAGR of 8.8% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Source Type (Fish Oil, Krill Oil, Algae Oil) • By Application Type (Food & beverage, Nutraceutical supplement, Pharmaceutical, Infant formula) • By End User (Adults, Geriatric, Pregnant Women, Children, Infants) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe [Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Nordic Naturals, Inc., NutriGold Inc., Reckitt Benckiser Group plc, Pharma Nord B.V, i-Health, Inc, Aker BioMarine AS, Luhua Biomarine (Shandong) Co., Ltd, Pharmavite LLC, KD Pharma Group, NOW Foods, GlaxoSmithKline plc, Natrol LLC, Carlson Laboratories, OmegaBrite, Optimum Nutrition, Inc., VAYA Pharma, Vital Choice Wild Seafood & Organics, SPC, Bionova, The Nature’s Bounty Co., Arkopharma |
| DRIVERS | • Chronic disease awareness is growing. • Increased attention to cognitive development |
| Restraints | • Lack of consumer understanding of the daily recommended consumption |
Ans: The Omega 3 supplements market is predicted to grow at a CAGR of 8.8% over the forecast period 2023-2032.
Ans: - The Omega 3 supplements Market size was valued at US$ 7 Bn in 2023.
North America is the most known region.
Yes, a data validation process is followed in this report.
Geriatric, Pregnant Women, and Children these are the end-users of omega 3 supplements market
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.1 Introduction
4.3.2 Impact on major economies
4.3.2.1 US
4.3.2.2 Canada
4.3.2.3 Germany
4.3.2.4 France
4.3.2.5 United Kingdom
4.3.2.6 China
4.3.2.7 Japan
4.3.2.8 South Korea
4.3.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Omega 3 supplements market Segmentation, by source type
8.1 Fish Oil
8.2 Krill Oil
8.3 Algae Oil
8.4 Others
9. Omega 3 supplements market Segmentation, by application type
9.1 Food & beverage
9.2 Nutraceutical supplement
9.3 Pharmaceutical
9.4 Infant formula
9.5 Others
10. Omega 3 supplements market Segmentation, By end user type
10.1 Adults
10.2 Geriatric
10.3 Pregnant Women
10.4 Children
10.5 Infants
11. Regional Analysis
11.1 Introduction
11.2 North America
11.2.1 USA
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 France
11.3.4 Italy
11.3.5 Spain
11.3.6 The Netherlands
11.3.7 Rest of Europe
11.4 Asia-Pacific
11.4.1 Japan
11.4.2 South Korea
11.4.3 China
11.4.4 India
11.4.5 Australia
11.4.6 Rest of Asia-Pacific
11.5 The Middle East & Africa
11.5.1 Israel
11.5.2 UAE
11.5.3 South Africa
11.5.4 Rest
11.6 Latin America
11.6.1 Brazil
11.6.2 Argentina
11.6.3 Rest of Latin America
12. Company Profiles
12.1 Nordic Naturals
12.1.1 Financial
12.1.2 Products/ Services Offered
12.1.3 SWOT Analysis
12.1.4 The SNS view
12.2 NutriGold Inc.
12.3 Reckitt Benckiser Group plc
12.5 Pharma Nord B.V
12.5 i-Health, Inc
12.6 Aker BioMarine AS
12.7 Luhua Biomarine (Shandong) Co., Ltd
12.8 Pharmavite LLC
12.9 KD Pharma Group
12.10 NOW Foods
12.11GlaxoSmithKline plc
12.12 Natrol LLC
12.13 Carlson Laboratories
12.14 OmegaBrite
12.13 Optimum Nutrition, Inc.
12.16 VAYA Pharma
12.17 Vital Choice Wild Seafood & Organics
12.18 SPC
12.19 Bionova,
12.20 The Nature’s Bounty Co.
12.21 Arkopharma
13. Competitive Landscape
13.1 Competitive Benchmark
13.2 Market Share Analysis
13.3 Recent Developments
14. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
By Source Type
Fish Oil
Algae Oil
Others
By Application Type
Nutraceutical supplement
Pharmaceutical
Infant formula
Others
By End-User
Adults
Geriatric
Pregnant Women
Children
Infants
Request for Segment Customization as per your Business Requirement: Segment Customization Request
REGIONAL COVERAGE:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five)
The Foot Orthotic Insoles Market size was valued at USD 3.65 Billion in 2023 and will reach USD 6.28 Billion By 2031 with a growing CAGR of 7% by 2024-2031.
The 3D Printing Medical Devices Market Size was valued at USD 2.93 billion in 2023 and is expected to reach USD 10.67 billion by 2031 and grow at a CAGR of 17.5% over the forecast period 2024-2031.
The Mental Health Market Size was valued at USD 411.99 billion in 2023 and is expected to reach USD 566.07 billion by 2032 and grow at a CAGR of 3.20% over the forecast period 2024-2032.
The Microbial Identification Market Size was valued at USD 3.6 Billion in 2023 and is expected to reach USD 9.77 Billion by 2032, growing at a CAGR of 11.5 % over the forecast period 2024-2032.
The Biotechnology Reagents & Kits Market size was estimated at USD 660.67 billion in 2023 and is expected to reach USD 1690.01 billion by 2032 with a growing CAGR of 11% during the forecast period of 2024-2032.
The Sleep Disorder Treatment Market Size was valued at USD 23.97 Billion in 2023 and is expected to reach USD 64.14 Billion by 2032 and grow at a CAGR of 12.17% over the forecast period 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
